Le Lézard
Classified in: Health
Subjects: CCA, PET, FVT

IDEXX Laboratories to Release 2017 Third Quarter Financial Results



WESTBROOK, Maine, Oct. 5, 2017 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2017 third quarter financial results for Tuesday, October 31, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Individuals can access a live webcast of the conference call through a link on the IDEXX website, www.idexx.com. An archived edition of the webcast will be available after 1:00 p.m. ET on that day via the same link and will remain available for one year.

The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-800-230-1092 or 1-612-288-0340 and reference confirmation code 431383. Replay of the conference call will be available through Tuesday, November 7, 2017 by dialing 1-800-475-6701 or 1-320-365-3844 and referencing replay code 431383.

IDEXX Laboratories, Inc. logo. (PRNewsFoto/IDEXX Laboratories, Inc.)

About IDEXX Laboratories
IDEXX Laboratories, Inc. is a member of the S&P 500® index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency, and build more economically successful practices. IDEXX is also a worldwide leader in providing livestock and poultry diagnostic tests and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 7,000 people and offers products to customers in over 175 countries. For more information about IDEXX, visit: www.idexx.com.

Contact:
Investor Relations:
Kerry Bennett   
207-556-8155

SOURCE IDEXX Laboratories, Inc.


These press releases may also interest you

at 08:03
Systemic sclerosis is a rare, serious chronic autoimmune disease with no approved therapyAffects approximately 90,000 individuals in US and EU and associated with 10-year mortality of 40-60%Corbus Pharmaceuticals Holdings, Inc. ("Corbus" or the...

at 08:03
Golden Leaf Holdings Ltd. ("GLH" or the "Company") , a leading cannabis oil solutions company and dispensary operator built around recognized brands, today announced that it has opened a new Chalice Farms dispensary on the popular Willamette River...

at 08:02
Geneia (www.Geneia.com), an analytic solutions and services company that is simplifying the evolution to value-based care, announced its new partnership with Salesforce Health Cloud to better serve the needs of health plans, hospitals, providers and...

at 08:00
The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has launched a new fund to provide copayment and premium assistance to Medicare patients living with acromegaly. Through the...

at 08:00
A Moody's Analytics report, prepared for the Blue Cross Blue Shield Association (BCBSA), was released today linking social determinants of health to differences in health across communities. Moody's Analytics utilized the Blue Cross Blue Shield...

at 08:00
Trovagene, Inc. , a precision medicine biotechnology company, engaged in the development of targeted cancer therapies, today announced the filing of its protocol for a Phase 2 clinical trial of PCM-075 in combination with abiraterone acetate (Zytiga®...




News published on 5 october 2017 at 14:00 and distributed by: